FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) from Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Stable Angina
• Supraventricular Tachycardia
• Vasospastic Angina

Drugs mentioned

• CARTIA XT (DILTIAZEM HYDROCHLORIDE)

Snippet

SUPPL AP for CARTIA XT (DILTIAZEM HYDROCHLORIDE)